©2022 Stanford Medicine
Open-Label Study of AG10 in Patients With Cardiomyopathy
Recruiting
Trial ID: NCT03536767
Purpose
This prospective, multicenter open-label study will evaluate the long-term safety,
tolerability, PK and PD of AG10 administered on a background of stable heart failure therapy.
Official Title
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
Stanford Investigator(s)
Ronald Witteles
Professor of Medicine (Cardiovascular Medicine)
Eligibility
Inclusion Criteria:
1. Completed participation in study AG10-201.
2. Willing and able to comply with the study medication regimen and all study
requirements.
3. The ability to understand and provide informed consent, which must be obtained prior
to initiation of study participation.
4. Male patients and female patients of childbearing potential who engage in heterosexual
intercourse must agree to use effective method(s) of contraception.
Exclusion Criteria:
1. Hemodynamic instability that would pose too great a risk to the subject.
2. Abnormalities in clinical laboratory tests that would pose too great a risk to the
subject.
3. Any clinically significant ongoing medical condition or any laboratory abnormality or
condition that could adversely affect the safety of the patient.
4. Known hypersensitivity to study drug (AG10), its metabolites, or formulation
excipients.
5. Likely to undergo heart transplantation or placement of a mechanical circulatory
device within the next year.
6. Receiving current treatment with diflunisal, tafamidis, green tea, doxycycline,
TUDCA/Ursodiol, patisiran, inotersen or any other investigational ATTR agent within 14
days or 5 half-lives of the prior investigational agent (whichever is longer) prior to
dosing with study drug.
7. Females who are pregnant or breastfeeding. Lactating females must agree to discontinue
nursing before the study drug is administered.
Intervention(s):
drug: AG10
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305